IceCure Medical Ltd (ICCM) Stock Analysis
NASDAQHealthcareMedical - Devices
What IceCure Medical Ltd does
Headquartered in Caesarea, Israel, and founded in 2006, IceCure Medical Ltd is a medical device enterprise dedicated to inventing, refining, and marketing innovative solutions for treating human tumors through cryoablation, a freezing process. Their primary offering, the ProSense system, provides a specialized cryoablation therapy specifically for breast tumors.
Key metrics
ETFs linked to ICCM
Broad-market and Healthcare sector ETFs an investor holding IceCure Medical Ltd is often also exposed to. Open an ETF page to see its actual top holdings.
PortView Portfolio Insights
PortView analyzes how ICCM fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze ICCM in PortView →Similar companies
Frequently asked questions
- What is the ticker symbol for IceCure Medical Ltd?
- IceCure Medical Ltd trades under the ticker ICCM on NASDAQ.
- Which exchange is ICCM listed on?
- ICCM is listed on NASDAQ.
- What sector does IceCure Medical Ltd operate in?
- IceCure Medical Ltd is classified in the Healthcare sector (Medical - Devices industry).
- How can PortView help analyze ICCM in a portfolio?
- PortView shows ICCM's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.